Articles
Fill and Finish in Clinical Development: Getting it Right from the Start
Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including...
Articles
The impact of the COVID 19 Pandemic on Global Pharmaceutical Growth
Vaccine production is very complex making specialist expertise vital to ensuring both the safety and efficacy of the final product. Depending on the type...
Drug Research
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial...
Press Releases
Dr Reddy’s Lab gets emergency use authorisation for Sputnik V in India
Dr. Reddy’s Laboratories Ltd. announced that it has received the permission from the Drug Controller General of India(DCGI)to import the Sputnik vaccine into India...
Drug Research
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through...
News
Malvern Panalytical and Concept Life Sciences announce integration
Malvern Panalytical, manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The...
News
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810
“As we prepare to advance ATYR2810 to clinical stage development, we are pleased to work with Lonza, a partner with extensive and proven capability...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read